Select Medical Holdings Co. (NYSE:SEM) Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its stake in Select Medical Holdings Co. (NYSE:SEM) by 9.7% during the third quarter, Holdings Channel reports. The firm owned 416,299 shares of the health services provider’s stock after purchasing an additional 36,905 shares during the period. JPMorgan Chase & Co.’s holdings in Select Medical were worth $14,516,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Point72 Asset Management L.P. lifted its holdings in shares of Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after acquiring an additional 1,216,263 shares in the last quarter. Millennium Management LLC lifted its holdings in shares of Select Medical by 183.9% during the 2nd quarter. Millennium Management LLC now owns 679,522 shares of the health services provider’s stock valued at $23,824,000 after acquiring an additional 440,140 shares in the last quarter. Hood River Capital Management LLC acquired a new position in shares of Select Medical during the 2nd quarter valued at $14,819,000. Loomis Sayles & Co. L P acquired a new position in shares of Select Medical during the 3rd quarter valued at $9,710,000. Finally, LMR Partners LLP acquired a new position in shares of Select Medical during the 3rd quarter valued at $6,139,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Stock Performance

Shares of SEM stock opened at $18.32 on Friday. Select Medical Holdings Co. has a 12 month low of $18.02 and a 12 month high of $40.98. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The firm has a market capitalization of $2.37 billion, a P/E ratio of 8.56, a P/E/G ratio of 0.39 and a beta of 1.45. The company’s fifty day moving average price is $25.44 and its two-hundred day moving average price is $31.67.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.07. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company’s revenue was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.46 EPS. On average, research analysts anticipate that Select Medical Holdings Co. will post 1.97 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were given a $0.125 dividend. This represents a $0.50 annualized dividend and a dividend yield of 2.73%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical’s payout ratio is currently 23.36%.

Insider Transactions at Select Medical

In related news, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now owns 22,000 shares of the company’s stock, valued at $463,980. This represents a 59.26 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the sale, the vice president now directly owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. This represents a 14.12 % decrease in their position. The disclosure for this sale can be found here. Insiders own 19.14% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on SEM shares. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a report on Tuesday. UBS Group cut their price objective on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Finally, Royal Bank of Canada boosted their price objective on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $39.50.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.